OSL oncosil medical ltd

Ann: OncoSil FY21 half yearly review, page-24

  1. 141 Posts.
    lightbulb Created with Sketch. 13
    My take is nothing will happen until there is some positive news, the whole CEO thing shook things even though ultimately I think there is a strong consensus with holders that it was long overdue and the replacement is amazing, until the new guy actually proves something new buyers will be a bit cautious. Annoyingly there is a huge abundance that could happen any day just none has yet which is why relatively speaking it is tightly held where the price is now. Examples of news are the Ability to actually sell anywhere in Europe. An approval in the US or even the news that the data package requested has been finalised. Additional NZ sales/sites. A TGA approval here in AUS. Even more annoyingly there’s so much compared to other shares I am aware of and it’s all so imminent that selling out has a very high chance of missing the run and we are extremely unlikely to breach 0.125 from what I’ve seen...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.010(0.86%)
Mkt cap ! $21.74M
Open High Low Value Volume
$1.17 $1.17 $1.14 $80.47K 69.48K

Buyers (Bids)

No. Vol. Price($)
1 2150 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.